
    
      This two-part study will assess the safety, tolerability, and pharmacokinetics (PK) of single
      ascending doses AZ-010 in healthy volunteers and will compare in a crossover design the
      safety and PK of a single dose of AZ-010 and IV granisetron.
    
  